Month: April 2019
-
Smartphone System Detects Diabetic Eye Disease
An ophthalmology lab at University of Michigan developed a smartphone-based system that speeds screening for an eye disease resulting from diabetes.
-
DNA Nanoscale Capsules Designed for Drug Delivery
Researchers in Finland developed tiny drug-delivery capsules made of folded pieces of DNA, with the capsules opening and closing in specified chemical environments.
-
FDA Approves Transplant Lung Preservation System
The Food and Drug Administration approved a medical device that restores and maintains lungs for transplants that may not otherwise be acceptable.
-
Closed-Loop System Boosts Diabetes Glucose Control
A clinical trial shows an algorithm-driven glucose monitor and insulin pump system provides better control of glucose levels for people with type 1 diabetes than an insulin pump alone.
-
Infographic – U.S. Leads in Unvaccinated for Measles
New statistics from Unicef show far more children in the U.S. did not receive their first measles vaccine dose between 2010 and 2017 than children in other countries.
-
Microrobot Swarm Breaks Up Bacterial Biofilms
A medical-engineering team designed tiny robots that in lab tests remove large patches of bacterial communities called biofilms found growing on medical devices and human teeth.
-
A.I. Speeds Infant Genetic Disease Diagnostics
Hospital, academic, and industry researchers devised automated techniques including artificial intelligence to sharply reduce the time for diagnosing genetic diseases in infants.
-
Natural-Sounding Speech Produced from Brain Signals
A neuroscience lab created a virtual speech-generating vocal system that produces natural sounding human speech by interpreting activity in the brain.
-
Simple Process Devised for Synthetic Mother-of-Pearl
Researchers in the U.S. and Europe developed a simple, inexpensive, and sustainable process to grow synthetic nacre, also known as mother-of-pearl.
-
Crispr Made More Immune-System Safe
Researchers at Arizona State University created a process to make the genome editing technique Crispr less likely to cause an immune system reaction in patients.